USE OF 2-HYDROXY OR 2-ACETYLOXY-4-TRIFLUOROMETHYLBENZOIC ACID DERIVATIVES AS AN AGENT FOR THE TREATMENT AND PREVENTION OF MILD COGNITIVE IMPAIRMENT

摘要

The present invention relates to the use of 2-hydroxy or 2-acetyloxy-4- trifluoromethylbenzoic acid, respectively, for the treatment or prevention of mild cognitive impairment (MCI) in mammals, especially in human beings. Futhermore, the present invention also concerns the use of 2-hydroxy or 2-acetyloxy-4-trifluoromethylbenzoic acid, respectively, for delaying or preventing the conversion of MCI into dementia, especially Alzheimer's Disease.